| Year |
Citation |
Score |
| 2024 |
Velasquez E, Savchenko E, Marmolejo-Martínez-Artesero S, Challuau D, Aebi A, Pomeshchik Y, Lamas NJ, Vihinen M, Rezeli M, Schneider B, Raoul C, Roybon L. TNFα prevents FGF4-mediated rescue of astrocyte dysfunction and reactivity in human ALS models. Neurobiology of Disease. 106687. PMID 39362568 DOI: 10.1016/j.nbd.2024.106687 |
0.648 |
|
| 2024 |
Pera EM, Nilsson-De Moura J, Pomeshchik Y, Roybon L, Milas I. Inhibition of the serine protease HtrA1 by SerpinE2 suggests an extracellular proteolytic pathway in the control of neural crest migration. Elife. 12. PMID 38634469 DOI: 10.7554/eLife.91864 |
0.612 |
|
| 2023 |
Pomeshchik Y, Velasquez E, Gil J, Klementieva O, Gidlöf R, Sydoff M, Bagnoli S, Nacmias B, Sorbi S, Westergren-Thorsson G, Gouras GK, Rezeli M, Roybon L. Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer's disease pathogenesis. Acta Neuropathologica Communications. 11: 150. PMID 37715247 DOI: 10.1186/s40478-023-01649-z |
0.654 |
|
| 2023 |
Pomeshchik Y, Klementieva O, Gil J, Martinsson I, Hansen MG, de Vries T, Sancho-Balsells A, Russ K, Savchenko E, Collin A, Vaz AR, Bagnoli S, Nacmias B, Rampon C, Sorbi S, et al. Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies. Stem Cell Reports. 18: 1244-1245. PMID 37163981 DOI: 10.1016/j.stemcr.2023.04.009 |
0.782 |
|
| 2022 |
Azevedo C, Teku G, Pomeshchik Y, Reyes JF, Chumarina M, Russ K, Savchenko E, Hammarberg A, Lamas NJ, Collin A, Gouras GK, Klementieva O, Hallbeck M, Taipa R, Vihinen M, et al. Parkinson's disease and multiple system atrophy patient iPSC-derived oligodendrocytes exhibit alpha-synuclein-induced changes in maturation and immune reactive properties. Proceedings of the National Academy of Sciences of the United States of America. 119: e2111405119. PMID 35294277 DOI: 10.1073/pnas.2111405119 |
0.715 |
|
| 2021 |
Pomeshchik Y, Klementieva O, Gil J, Martinsson I, Hansen MG, de Vries T, Sancho-Balsells A, Russ K, Savchenko E, Collin A, Vaz AR, Bagnoli S, Nacmias B, Rampon C, Sorbi S, et al. Human iPSC-derived hippocampal spheroids: An innovative tool for stratifying Alzheimer disease patient-specific cellular phenotypes and developing therapies. Stem Cell Reports. 16: 2838. PMID 34758331 DOI: 10.1016/j.stemcr.2021.10.003 |
0.782 |
|
| 2021 |
Russ K, Teku G, Bousset L, Redeker V, Piel S, Savchenko E, Pomeshchik Y, Savistchenko J, Stummann TC, Azevedo C, Collin A, Goldwurm S, Fog K, Elmer E, Vihinen M, et al. TNF-α and α-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respiration. Cell Reports. 34: 108895. PMID 33761362 DOI: 10.1016/j.celrep.2021.108895 |
0.756 |
|
| 2021 |
Keuters MH, Keksa-Goldsteine V, Dhungana H, Huuskonen MT, Pomeshchik Y, Savchenko E, Korhonen PK, Singh Y, Wojciechowski S, Lehtonen Š, Kanninen KM, Malm T, Sirviö J, Muona A, Koistinaho M, et al. An arylthiazyne derivative is a potent inhibitor of lipid peroxidation and ferroptosis providing neuroprotection in vitro and in vivo. Scientific Reports. 11: 3518. PMID 33568697 DOI: 10.1038/s41598-021-81741-3 |
0.739 |
|
| 2020 |
Pomeshchik Y, Klementieva O, Gil J, Martinsson I, Hansen MG, de Vries T, Sancho-Balsells A, Russ K, Savchenko E, Collin A, Vaz AR, Bagnoli S, Nacmias B, Rampon C, Sorbi S, et al. Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies. Stem Cell Reports. PMID 32589876 DOI: 10.1016/J.Stemcr.2020.06.001 |
0.767 |
|
| 2020 |
Azevedo C, Chumarina M, Serafimova E, Goldwurm S, Collin A, Roybon L, Savchenko E, Pomeshchik Y. Generation of an induced pluripotent stem cell line (CSC-32) from a patient with Parkinson's disease carrying a heterozygous variation p.A53T in the SNCA gene. Stem Cell Research. 43: 101694. PMID 31954327 DOI: 10.1016/J.Scr.2019.101694 |
0.783 |
|
| 2019 |
Korhonen P, Pollari E, Kanninen KM, Savchenko E, Lehtonen Š, Wojciechowski S, Pomeshchik Y, Van Den Bosch L, Goldsteins G, Koistinaho J, Malm T. Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis. Ibro Reports. 6: 74-86. PMID 30705990 DOI: 10.1016/J.Ibror.2019.01.005 |
0.731 |
|
| 2018 |
Gustavsson N, Marote A, Pomeshchik Y, Russ K, Azevedo C, Chumarina M, Goldwurm S, Collin A, Pinto L, Salgado AJ, Klementieva O, Roybon L, Savchenko E. Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene. Stem Cell Research. 34: 101373. PMID 30640063 DOI: 10.1016/J.Scr.2018.101373 |
0.75 |
|
| 2018 |
Loppi S, Kolosowska N, Kärkkäinen O, Korhonen P, Huuskonen M, Grubman A, Dhungana H, Wojciechowski S, Pomeshchik Y, Giordano M, Kagechika H, White A, Auriola S, Koistinaho J, Landreth G, et al. HX600, a synthetic agonist for RXR-Nurr1 heterodimer complex, prevents ischemia-induced neuronal damage. Brain, Behavior, and Immunity. PMID 30063972 DOI: 10.1016/J.Bbi.2018.07.021 |
0.508 |
|
| 2018 |
Marote A, Pomeshchik Y, Collin A, Goldwurm S, Lamas NJ, Pinto L, Salgado AJ, Roybon L. Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene. Stem Cell Research. 28: 44-47. PMID 29414418 DOI: 10.1016/J.Scr.2018.01.022 |
0.761 |
|
| 2018 |
Marote A, Pomeshchik Y, Goldwurm S, Collin A, Lamas NJ, Pinto L, Salgado AJ, Roybon L. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene. Stem Cell Research. 27: 90-94. PMID 29353703 DOI: 10.1016/J.Scr.2018.01.006 |
0.753 |
|
| 2018 |
Marote A, Pomeshchik Y, Goldwurm S, Collin A, Lamas NJ, Pinto L, Salgado AJ, Roybon L. Generation of an integration-free induced pluripotent stem cell line (CSC-43J) from a patient with sporadic Parkinson's disease. Stem Cell Research. 27: 82-85. PMID 29334630 DOI: 10.1016/J.Scr.2018.01.007 |
0.771 |
|
| 2018 |
Savchenko E, Marote A, Russ K, Collin A, Goldwurm S, Roybon L, Pomeshchik Y. Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease. Stem Cell Research. 27: 78-81. PMID 29334629 DOI: 10.1016/J.Scr.2018.01.002 |
0.816 |
|
| 2018 |
Russ K, Marote A, Savchenko E, Collin A, Goldwurm S, Pomeshchik Y, Roybon L. Generation of a human induced pluripotent stem cell line (CSC-40) from a Parkinson's disease patient with a PINK1 p.Q456X mutation. Stem Cell Research. 27: 61-64. PMID 29331938 DOI: 10.1016/J.Scr.2018.01.001 |
0.82 |
|
| 2017 |
Djelloul M, Azevedo C, Pomeshchik Y, Hammarberg A, Roybon L. Reporting on methods to generate and purify rodent and human oligodendrocytes from different sources. Stem Cell Research. 20: 58-66. PMID 28395742 DOI: 10.1016/J.Scr.2017.02.008 |
0.77 |
|
| 2017 |
Huuskonen MT, Tuo QZ, Loppi S, Dhungana H, Korhonen P, McInnes LE, Donnelly PS, Grubman A, Wojciechowski S, Lejavova K, Pomeshchik Y, Periviita L, Kosonen L, Giordano M, Walker FR, et al. The Copper bis(thiosemicarbazone) Complex Cu(II)(atsm) Is Protective Against Cerebral Ischemia Through Modulation of the Inflammatory Milieu. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 28050710 DOI: 10.1007/S13311-016-0504-9 |
0.458 |
|
| 2016 |
Lemarchant S, Dunghana H, Pomeshchik Y, Leinonen H, Kolosowska N, Korhonen P, Kanninen KM, García-Berrocoso T, Montaner J, Malm T, Koistinaho J. Anti-inflammatory effects of ADAMTS-4 in a mouse model of ischemic stroke. Glia. 64: 1492-507. PMID 27301579 DOI: 10.1002/Glia.23017 |
0.459 |
|
| 2016 |
Lemarchant S, Pomeshchik Y, Kidin I, Kärkkäinen V, Valonen P, Lehtonen S, Goldsteins G, Malm T, Kanninen K, Koistinaho J. Erratum to: ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis. Molecular Neurodegeneration. 11: 15. PMID 26858022 DOI: 10.1186/S13024-016-0080-9 |
0.424 |
|
| 2016 |
Lemarchant S, Pomeshchik Y, Kidin I, Kärkkäinen V, Valonen P, Lehtonen S, Goldsteins G, Malm T, Kanninen K, Koistinaho J. ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis. Molecular Neurodegeneration. 11: 10. PMID 26809777 DOI: 10.1186/S13024-016-0078-3 |
0.478 |
|
| 2015 |
Kanninen KM, Pomeshchik Y, Leinonen H, Malm T, Koistinaho J, Levonen AL. Applications of the Keap1-Nrf2 system for gene and cell therapy. Free Radical Biology & Medicine. 88: 350-61. PMID 26164630 DOI: 10.1016/J.Freeradbiomed.2015.06.037 |
0.527 |
|
| 2015 |
Pomeshchik Y, Puttonen KA, Kidin I, Ruponen M, Lehtonen S, Malm T, Åkesson E, Hovatta O, Koistinaho J. Transplanted Human Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Do Not Promote Functional Recovery of Pharmacologically Immunosuppressed Mice With Contusion Spinal Cord Injury. Cell Transplantation. 24: 1799-812. PMID 25203632 DOI: 10.3727/096368914X684079 |
0.505 |
|
| 2015 |
Pomeshchik Y, Kidin I, Korhonen P, Savchenko E, Jaronen M, Lehtonen S, Wojciechowski S, Kanninen K, Koistinaho J, Malm T. Interleukin-33 treatment reduces secondary injury and improves functional recovery after contusion spinal cord injury. Brain, Behavior, and Immunity. 44: 68-81. PMID 25153903 DOI: 10.1016/J.Bbi.2014.08.002 |
0.704 |
|
| 2014 |
Kärkkäinen V, Pomeshchik Y, Savchenko E, Dhungana H, Kurronen A, Lehtonen S, Naumenko N, Tavi P, Levonen AL, Yamamoto M, Malm T, Magga J, Kanninen KM, Koistinaho J. Nrf2 regulates neurogenesis and protects neural progenitor cells against Aβ toxicity. Stem Cells (Dayton, Ohio). 32: 1904-16. PMID 24753106 DOI: 10.1002/Stem.1666 |
0.758 |
|
| 2014 |
Pomeshchik Y, Kidin I, Savchenko E, Rolova T, Yamamoto M, Levonen AL, Ylä-Herttuala S, Malm T, Kanninen K, Koistinaho J. Does Nrf2 gene transfer facilitate recovery after contusion spinal cord injury? Antioxidants & Redox Signaling. 20: 1313-23. PMID 23841575 DOI: 10.1089/ars.2013.5453 |
0.722 |
|
| 2012 |
Puli L, Pomeshchik Y, Olas K, Malm T, Koistinaho J, Tanila H. Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer's disease. Journal of Neuroinflammation. 9: 105. PMID 22642812 DOI: 10.1186/1742-2094-9-105 |
0.512 |
|
| Show low-probability matches. |